Pharmaceuticals news FT.com

Swiss drugmaker Novartis to invest $23bn in US manufacturing and R&D

Pharma group builds out American supply chains as part of preparations for potential US tariffs

May 12, 2025 - 09:54
 0
Swiss drugmaker Novartis to invest $23bn in US manufacturing and R&D
Pharma group builds out American supply chains as part of preparations for potential US tariffs
Read More

Tags:

Previous Article

Trump tariffs bring furrowed brows to Ireland’s Botox town

Next Article

STAT+: Up and down the ladder: The latest comings and goings

Related Posts

Roche to spend $50bn on US manufacturing and R&D

Roche to spend $50bn on US manufacturing and R&D

May 12, 2025  0

GSK turns to AI to offset potential US tariff hit

GSK turns to AI to offset potential US tariff hit

May 12, 2025  0

NHS signs deal with Scancell in ambitious skin cancer trial

NHS signs deal with Scancell in ambitious skin cancer t...

May 12, 2025  0